New copper-64 and gallium-68 chelating platforms are being developed by Macrocyclics, a subsidiary of AREVA Med, the company announced Jan. 10. Four new formulas would expand the company’s PET imaging portfolio. {read more here}

A PET/CT study followed 40 sufferers of heart attacks and just as many matched controls imaged with conventional coronary angiography and sodium fluoride PET/CT to gauge vulnerable plaques and see potential risk of heart attack. {read more here}

A Danish study published online January 22 in the Oncologist shows that PET/CT and biomarkers can help clinicians predict treatment response in patients with metastatic colon cancer.  Dr. Bodil Engelmann, from Næstved Hospital, and colleagues conducted a prospective study to determine the predictive value of several established biomarkers and FDG-PET/CT in the early response of metastatic colon cancer to treatment with chemotherapy. {read more here}

The lack of governance and regulatory guidelines relating to the use of mobile devices in medical workplaces have serious implications for clinical care, professional practice and the education of healthcare professionals, according to results of a study announced by researchers at Australia’s Monash University. {read more here}